Columbia Contrarian Core-I3COFYX
13F holders, Q2 2025 (June 30)2holders +1
1new positions
0sold out
$38.70avg. 13F price*
At the end of Q2 2025, 2 institutions reported holding Columbia Contrarian Core-I3 (COFYX) in their 13F filings, up 1 from Q1 2025. 1 opened new positions and 0 sold out. The largest holders were First Merchants Corp. ($275K) and Coston, McIsaac & Partners ($55K).
- Company
- Columbia Contrarian Core-I3
- CUSIP
- 19766M709
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $275K |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 7,094 shares bought, net +7,094 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| First Merchants Corp. | 0.01% | New | 7,094 | $275K |
| Coston, McIsaac & Partners | 0.01% | No change | 1,440 | $55K |
"% of holder's portfolio" is COFYX's weight in each manager's 13F, not the share of Columbia Contrarian Core-I3 the manager owns.